SCHEMBL20049992

SCHEMBL20049992

C=C(C)Nc1ncc(-c2ccccc2C)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.39
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
ABL1 P00519 1/20 0.38
KIT P10721 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GRIN2B Q13224 6/20 0.37
GRIN1 Q05586 4/20 0.37
JAK3 P52333 2/20 0.37
LCK P06239 1/20 0.37
KDR P35968 1/20 0.37
MAPK14 Q16539 1/20 0.37
USP2 O75604 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20049886 0.85 PSMB5 (0.42) CLK4KDRNPC1HTTRAB9A
SCHEMBL25588722 0.84 GRM5 (0.46) CYP1A2CYP3A4ALDH1A1TSHRCYP2C19
SCHEMBL20049904 0.83 GRIN2B (0.42) ALDH1A1ABL1GRIN2BGRIN1NPC1
SCHEMBL20049825 0.82 GSK3B (0.42) ALDH1A1CLK4GRIN2BGRIN1NPC1
SCHEMBL25588340 0.80 CYP1A2 (0.53) CNR1CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL25588074 0.79 CHRNA7 (0.38) CYP1A2ALDH1A1CYP2C19L3MBTL1NPC1
SCHEMBL20049948 0.79 ABL1 (0.43) ALDH1A1ABL1L3MBTL1GRIN2BGRIN1
SCHEMBL20049830 0.78 EGLN1 (0.41) CNR1KITGRIN2BGRIN1
SCHEMBL20050100 0.78 GRM5 (0.34) CYP1A2CYP3A4ALDH1A1TSHRCYP2C19
SCHEMBL25588536 0.78 ABL1 (0.43) ALDH1A1ABL1KITNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067786-A1 SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-12 WO disclosed